← Leaderboards
Pamela J Bjorkman
California Institute Of Technology
$57,868,021
Attributed
$57,868,021
Total exposure
43
Grants
38
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $15.3M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$103,524,128 · 45
By mechanism
P01$77,583,540 · 19
R01$5,627,706 · 4
U54$5,416,337 · 2
P50$4,385,678 · 3
DP1$4,204,948 · 2
R37$3,726,020 · 1
Top collaborators
- Michel C Nussenzweig15 shared
- Jeffrey Victor Ravetch5 shared
- Paul D Bieniasz2 shared
- Marina Caskey2 shared
- Beatrice H Hahn2 shared
- Theodora Hatziioannou2 shared
- Charles M. Rice2 shared
Most similar at California Institute Of Technology
Same institution · by research overlap
- Michel C Nussenzweig$48,766,293
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignAntibodiesStructureNeutralizing AntibodyHiv-1ProteinsAntigensVaccinesExperimental StudyBindingComplexCellsBaseVirusInfectionCollaborationsViralImmunoglobulin GPolysaccharidesIn VitroAnimalsAffinityImmunizationBinding Sites
Grant awards (146)
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$4,026,004
P01 · FY2025 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$1,655,505
P01 · FY2025 · AI · contact PI
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics$1,394,827
U54 · FY2025 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$846,737
P01 · FY2025 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$824,500
P01 · FY2025 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$577,150
P01 · FY2025 · AI · contact PI
Characterization of HCV vaccine induced-neutralizing antibody response in non-human primates$532,252
U19 · FY2025 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$122,112
P01 · FY2025 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$4,197,323
P01 · FY2024 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$1,724,205
P01 · FY2024 · AI · contact PI
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics$1,091,592
U54 · FY2024 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$890,425
P01 · FY2024 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$850,000
P01 · FY2024 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$595,000
P01 · FY2024 · AI · contact PI
Characterization of HCV vaccine induced-neutralizing antibody response in non-human primates$375,936
U19 · FY2024 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$137,693
P01 · FY2024 · AI · contact PI
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics$62,179
U54 · FY2024 · AI · contact PI
Broad neutralization of pandemic threat coronaviruses$4,259,011
P01 · FY2023 · AI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$2,208,763
P01 · FY2023 · AI · contact PI
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics$1,707,426
U54 · FY2023 · AI · contact PI
Structural Characterization of Coronavirus Antibodies Raised by Infection and Vaccination$971,500
P01 · FY2023 · AI · contact PI
Project 2: Design and screening for immunogens to efficiently elicit anti-HIV-1 bNAbs$650,413
P01 · FY2023 · AI · contact PI
Project 1: Immunization strategies to elicit broadly neutralizing antibodies against HIV-1$593,540
P01 · FY2023 · AI · contact PI
Core A: Automated Cell/Biochemical Assays Core$414,828
P01 · FY2023 · AI · contact PI
Core B: Protein Expression Core$411,538
P01 · FY2023 · AI · contact PI
Characterization of HCV vaccine induced-neutralizing antibody response in non-human primates$371,435
U19 · FY2023 · AI · contact PI
Core C: Administrative Core$138,444
P01 · FY2023 · AI · contact PI
Broad neutralization of pandemic threat coronaviruses$6,423,268
P01 · FY2022 · AI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$2,654,146
P01 · FY2022 · AI · contact PI
Structural Characterization of Coronavirus Antibodies Raised by Infection and Vaccination$1,507,637
P01 · FY2022 · AI · contact PI
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics$1,160,313
U54 · FY2022 · AI · contact PI
Project 1: Immunization strategies to elicit broadly neutralizing antibodies against HIV-1$1,004,305
P01 · FY2022 · AI · contact PI
Project 2: Design and screening for immunogens to efficiently elicit anti-HIV-1 bNAbs$636,015
P01 · FY2022 · AI · contact PI
Project 2$509,741
P01 · FY2022 · AI · contact PI
Core A: Automated Cell/Biochemical Assays Core$418,391
P01 · FY2022 · AI · contact PI
Core B: Protein Expression Core$418,390
P01 · FY2022 · AI · contact PI
Characterization of HCV vaccine induced-neutralizing antibody response in non-human primates$368,613
U19 · FY2022 · AI · contact PI
Core C: Administrative Core$177,045
P01 · FY2022 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$2,619,302
P01 · FY2021 · AI · contact PI
Project 1: Immunization strategies to elicit broadly neutralizing antibodies against HIV-1$1,065,397
P01 · FY2021 · AI · contact PI
Project 2: Design and screening for immunogens to efficiently elicit anti-HIV-1 bNAbs$593,250
P01 · FY2021 · AI · contact PI
Project 2$585,007
P01 · FY2021 · AI · contact PI
Virus Transmission$501,971
P50 · FY2021 · AI · contact PI
Core B: Protein Expression Core$411,250
P01 · FY2021 · AI · contact PI
Core A: Automated Cell/Biochemical Assays Core$411,250
P01 · FY2021 · AI · contact PI
Targeting the HIV reservoir using optimized anti-HIV antibodies$410,750
R01 · FY2021 · AI · contact PI
Characterization of HCV vaccine induced-neutralizing antibody response in non-human primates$392,336
U19 · FY2021 · AI · contact PI
Project 1: Immunization strategies to elicit broadly neutralizing antibodies against HIV-1$139,981
P01 · FY2021 · AI · contact PI
Enhancement of the HIV Antibody Database tool for Open Science$139,981
P01 · FY2021 · AI · contact PI
Core C: Administrative Core$138,155
P01 · FY2021 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$2,711,483
P01 · FY2020 · AI · contact PI
Project 1: Immunization strategies to elicit broadly neutralizing antibodies against HIV-1$856,199
P01 · FY2020 · AI · contact PI
Project 2: Design and screening for immunogens to efficiently elicit anti-HIV-1 bNAbs$845,350
P01 · FY2020 · AI · contact PI
Project 2$585,006
P01 · FY2020 · AI · contact PI
Virus Transmission$464,672
P50 · FY2020 · AI · contact PI
Core B: Protein Expression Core$460,439
P01 · FY2020 · AI · contact PI
Core A: Automated Cell/Biochemical Assays Core$411,319
P01 · FY2020 · AI · contact PI
Targeting the HIV reservoir using optimized anti-HIV antibodies$410,750
R01 · FY2020 · AI · contact PI
Core C: Administrative Core$138,176
P01 · FY2020 · AI · contact PI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies$2,561,973
P01 · FY2019 · AI · contact PI
Project 2: Design and screening for immunogens to efficiently elicit anti-HIV-1 bNAbs$668,268
P01 · FY2019 · AI · contact PI
Virus Transmission$657,558
P50 · FY2019 · AI · contact PI
Project 1: Immunization strategies to elicit broadly neutralizing antibodies against HIV-1$609,375
P01 · FY2019 · AI · contact PI
Core A: Automated Cell/Biochemical Assays Core$606,250
P01 · FY2019 · AI · contact PI
Project 2$585,006
P01 · FY2019 · AI · contact PI
Core B: Protein Expression Core$539,555
P01 · FY2019 · AI · contact PI
Targeting the HIV reservoir using optimized anti-HIV antibodies$410,750
R01 · FY2019 · AI · contact PI
Core C: Administrative Core$138,525
P01 · FY2019 · AI · contact PI
Project 2$602,381
P01 · FY2018 · AI · contact PI
Virus Transmission$570,989
P50 · FY2018 · GM · contact PI
Fc receptor/Ig interactions and trafficking$416,250
R01 · FY2018 · AI · contact PI
Targeting the HIV reservoir using optimized anti-HIV antibodies$410,750
R01 · FY2018 · AI · contact PI
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies$2,100,311
P01 · FY2017 · AI · contact PI
Virus Transmission$623,695
P50 · FY2017 · GM · contact PI
Stuctural basis of bNab activity$476,328
P01 · FY2017 · AI · contact PI
Fc receptor/Ig interactions and trafficking$416,250
R01 · FY2017 · AI · contact PI
Targeting the HIV reservoir using optimized anti-HIV antibodies$410,750
R01 · FY2017 · AI · contact PI
Protein Expression$226,994
P01 · FY2017 · AI · contact PI
Administrative Core$111,962
P01 · FY2017 · AI · contact PI
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies$4,894,251
P01 · FY2016 · AI · contact PI
Stuctural basis of bNab activity$2,012,091
P01 · FY2016 · AI · contact PI
Fc receptor/Ig interactions and trafficking$416,250
R01 · FY2016 · AI · contact PI
Tissue EM Core$344,172
P50 · FY2016 · GM · contact PI
Protein Expression$168,548
P01 · FY2016 · AI · contact PI
Administrative Core$94,893
P01 · FY2016 · AI · contact PI
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies$2,100,313
P01 · FY2015 · AI · contact PI
Stuctural basis of bNab activity$458,442
P01 · FY2015 · AI · contact PI
Fc receptor/Ig interactions and trafficking$416,250
R01 · FY2015 · AI · contact PI
Tissue EM Core$305,735
P50 · FY2015 · GM · contact PI
Protein Expression$229,819
P01 · FY2015 · AI · contact PI
Administrative Core$68,143
P01 · FY2015 · AI · contact PI
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies$2,636,665
P01 · FY2014 · AI · contact PI
Thwarting HIV evasion of antibody avidity with novel antibody architectures$801,900
DP1 · FY2014 · DA · contact PI
Stuctural basis of bNab activity$497,670
P01 · FY2014 · AI · contact PI
Fc receptor/Ig interactions and trafficking$416,250
R01 · FY2014 · AI · contact PI
Tissue EM Core$297,523
P50 · FY2014 · GM · contact PI
Protein Expression$272,081
P01 · FY2014 · AI · contact PI
Administrative Core$55,375
P01 · FY2014 · AI · contact PI
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies$2,123,313
P01 · FY2013 · AI · contact PI
Thwarting HIV evasion of antibody avidity with novel antibody architectures$793,342
DP1 · FY2013 · DA · contact PI
Analysis of the Neonatal Fc Receptor/IgG Interaction$385,939
R37 · FY2013 · AI · contact PI
Stuctural basis of bNab activity$345,559
P01 · FY2013 · AI · contact PI
Tissue EM Core$282,827
P50 · FY2013 · GM · contact PI
Protein Expression$173,232
P01 · FY2013 · AI · contact PI
Administrative Core$51,365
P01 · FY2013 · AI · contact PI
Thwarting HIV evasion of antibody avidity with novel antibody architectures$908,756
DP1 · FY2012 · DA · contact PI
Analysis of the Neonatal Fc Receptor/IgG Interaction$410,573
R37 · FY2012 · AI · contact PI
Tissue EM Core$336,536
P50 · FY2012 · GM · contact PI
Thwarting HIV evasion of antibody avidity with novel antibody architectures$89,050
DP1 · FY2012 · OD · contact PI
Structural Basis of Antibody-Mediated Neutralization of HIV$1
R01 · FY2012 · AI · contact PI
Thwarting HIV evasion of antibody avidity with novel antibody architectures$801,900
DP1 · FY2011 · OD · contact PI
Analysis of the Neonatal Fc Receptor/IgG Interaction$410,736
R37 · FY2011 · AI · contact PI
BJORKMAN 12-2 PRT$5,753
P41 · FY2011 · RR · contact PI
Thwarting HIV evasion of antibody avidity with novel antibody architectures$810,000
DP1 · FY2010 · OD · contact PI
Analysis of the Neonatal Fc Receptor/IgG Interaction$414,874
R37 · FY2010 · AI · contact PI
BJORKMAN 12-2 PRT$4,738
P41 · FY2010 · RR · contact PI
Analysis of the Neonatal Fc Receptor/IgG Interaction$404,029
R37 · FY2009 · AI · contact PI
Analysis of the Neonatal Fc Receptor/IgG Interaction$332,184
R37 · FY2008 · AI · contact PI
STRUCTURE OF THE FCRN RECEPTOR$36,853
P41 · FY2008 · RR · contact PI
STRUCTURES OF PROSTATE SPECIFIC MEMBRANE ANTIGEN, PIGR, A GE/GI-FC AND AN ANTI-P$757
P41 · FY2008 · RR · contact PI
Analysis of the Neonatal Fc Receptor/IgG Interaction$338,617
R37 · FY2007 · AI · contact PI
Biochemistry /structure comparison of transferrin receptors$56,517
P01 · FY2007 · GM · contact PI
STRUCTURE OF THE FCRN RECEPTOR$17,230
P41 · FY2007 · RR · contact PI
STRUCTURES OF PROSTATE SPECIFIC MEMBRANE ANTIGEN, PIGR, A GE/GI-FC AND AN ANTI-P$1,387
P41 · FY2007 · RR · contact PI
Analysis of the Neonatal Fc Receptor/IgG Interaction$348,731
R37 · FY2006 · AI · contact PI
HFE/Transferrin Receptor/Transferrin Interactions$249,985
R01 · FY2006 · DK · contact PI
Biochemistry /structure comparison of transferrin recept$42,616
P01 · FY2006 · GM · contact PI
STRUCTURES OF PROSTATE SPECIFIC MEMBRANE ANTIGEN, PIGR, A GE/GI-FC AND AN ANTI-P$855
P41 · FY2006 · RR · contact PI
Analysis of the Neonatal Fc Receptor/IgG Interaction$357,123
R37 · FY2005 · AI
HFE/Transferrin Receptor/Transferrin Interactions$256,211
R01 · FY2005 · DK
Biochemistry /structure comparison of transferrin recept$41,375
P01 · FY2005 · GM
STRUCTURES OF PROSTATE SPECIFIC MEMBRANE ANTIGEN, PIGR, A GE/GI-FC AND AN ANTI-P$2,381
P41 · FY2005 · RR
Analysis of the Neonatal Fc Receptor/IgG Interaction$323,214
R37 · FY2004 · AI
HFE/Transferrin Receptor/Transferrin Interactions$256,415
R01 · FY2004 · DK
Biochemistry /structure comparison of transferrin recept$40,170
P01 · FY2004 · GM
STRUCTURE OF THE FCRN RECEPTOR$27,217
P41 · FY2004 · RR
Struc Determin of Supramolec Machines by Hybrid Methods$10,000
R13 · FY2004 · GM
CRYOPRESERVED CRYSTALS OF ZN-ALPHA2-GLYCOPROTEIN, INVASIN &FC-ALPHA-R$2,628
P41 · FY2004 · RR
HFE/Transferrin Receptor/Transferrin Interactions$256,613
R01 · FY2003 · DK
Biochemistry /structure comparison of transferrin recept$39,000
P01 · FY2003 · GM
HFE/Transferrin Receptor/Transferrin Interactions$256,804
R01 · FY2002 · DK
CRYOPRESERVED CRYSTALS OF HEMOLIN, FASCICLIN III &HIGH PH NEONATAL FC RECEPTOR$143,176
P41 · FY2002 · RR
CRYOPRESERVED CRYSTALS OF HEMOLIN, FASCICLIN III &HIGH PH NEONATAL FC RECEPTOR$143,176
P41 · FY2002 · RR
CRYOPRESERVED CRYSTALS OF HEMOLIN, FASCICLIN III &HIGH PH NEONATAL FC RECEPTOR$143,176
P41 · FY2001 · RR
NEONATAL FC RECEPTOR/IGG INTERACTION$109,940
R01 · FY2001 · AI
NEONATAL FC RECEPTOR/IGG INTERACTION$106,737
R01 · FY2000 · AI